Literature DB >> 2944814

Regional assignment of human liver-type 6-phosphofructokinase to chromosome 21q22.3 by using somatic cell hybrids and a monoclonal anti-L antibody.

M Van Keuren, H Drabkin, I Hart, D Harker, D Patterson, S Vora.   

Abstract

The three structural loci encoding human phosphofructokinase, a key regulatory enzyme of glycolysis, are located on separate chromosomes. The gene coding for the liver-type subunit PFKL has previously been assigned to chromosome 21. We have used a subunit- and human-specific monoclonal antibody to liver PFK to detect the expression of human PFKL in hamster X human hybrid cell lines. A cell line carrying an 8;21 translocation which contains all of chromosome 21 except the band 21q22.3 was negative for the expression of PFKL whereas cell lines carrying the reciprocal 8;21 translocation were positive. In addition, a cell line with a ring chromosome 21 containing a breakpoint which excluded the distal part of the q22.3 band was negative for expression of PFKL. These results indicate that human PFKL is located on chromosome 21q22.3.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2944814     DOI: 10.1007/bf00278782

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  41 in total

1.  Partial trisomies of chromosome 21 in man. Two new observations due to translocations 19;21 and 4;21.

Authors:  R A Pfeiffer; E K Kessel; K H Soer
Journal:  Clin Genet       Date:  1977-03       Impact factor: 4.438

2.  Regional localization of DNA sequences on chromosome 21 using somatic cell hybrids.

Authors:  M L Van Keuren; P C Watkins; H A Drabkin; E W Jabs; J F Gusella; D Patterson
Journal:  Am J Hum Genet       Date:  1986-06       Impact factor: 11.025

3.  Comparative gene mapping of human chromosome 21 and mouse chromosome 16.

Authors:  D R Cox; C J Epstein
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

4.  Blood cell enzymes in translocation Down's syndrome.

Authors:  R S Sparkes; M A Baughan
Journal:  Am J Hum Genet       Date:  1969-09       Impact factor: 11.025

5.  Enzymes in Down's syndrome.

Authors:  H Bartels; K Kruse; M Tolksdorf
Journal:  Lancet       Date:  1968-04-13       Impact factor: 79.321

6.  Platelet-phosphohexokinase levels in Down's syndrome.

Authors:  J C Doery; J Hirsh; O M Garson; G C de Gruchy
Journal:  Lancet       Date:  1968-10-26       Impact factor: 79.321

7.  Assignment of the gene for F-type phosphofructokinase to human chromosome 10 by somatic cell hybridization and specific immunoprecipitation.

Authors:  D Weil; D Cottreau; R Rebourcet; C Foubert; M S Gross; J C Dreyfus; A Kahn
Journal:  Ann Hum Genet       Date:  1980-07       Impact factor: 1.670

8.  Trisomy 21 for the region 21q223: identification by high-resolution R-banding patterns.

Authors:  J F Mattei; M G Mattei; M A Baeteman; F Giraud
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

9.  Familial Down syndrome due to t(10;21) translocation: evidence that the Down phenotype is related to trisomy of a specific segment of chromosome 21.

Authors:  J D Williams; R L Summitt; P R Martens; R A Kimbrell
Journal:  Am J Hum Genet       Date:  1975-07       Impact factor: 11.025

10.  Down's syndrome phenotype and autosomal gene inactivation in a child with presumed (X;21) de novo translocation.

Authors:  K Taysi; R S Sparkes; T J O'Brien; D R Dengler
Journal:  J Med Genet       Date:  1982-04       Impact factor: 6.318

View more
  13 in total

1.  Regional chromosomal assignment of the human platelet phosphofructokinase gene to 10p15.

Authors:  N Morrison; C Simpson; L Fothergill-Gilmore; E Boyd; J M Connor
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

2.  Glycogenosis type VII (Tarui disease) in a Swedish family: two novel mutations in muscle phosphofructokinase gene (PFK-M) resulting in intron retentions.

Authors:  R C Nichols; O Rudolphi; B Ek; R Exelbert; P H Plotz; N Raben
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

3.  Isolation of chromosome-21-specific DNA probes and their use in the analysis of nondisjunction in Down syndrome.

Authors:  J Galt; E Boyd; J M Connor; M A Ferguson-Smith
Journal:  Hum Genet       Date:  1989-01       Impact factor: 4.132

4.  Confirmation of assignment of the human alpha 1-crystallin gene (CRYA1) to chromosome 21 with regional localization to q22.3.

Authors:  J W Hawkins; M L Van Keuren; J Piatigorsky; M L Law; D Patterson; F T Kao
Journal:  Hum Genet       Date:  1987-08       Impact factor: 4.132

5.  A DNA polymorphism with KpnI of the human liver-type phosphofructokinase (PFKL) gene.

Authors:  A C Warren; Y Groner; S E Antonarakis
Journal:  Nucleic Acids Res       Date:  1988-09-26       Impact factor: 16.971

6.  Nonsense mutation in the phosphofructokinase muscle subunit gene associated with retention of intron 10 in one of the isolated transcripts in Ashkenazi Jewish patients with Tarui disease.

Authors:  O Vasconcelos; K Sivakumar; M C Dalakas; M Quezado; J Nagle; M Leon-Monzon; M Dubnick; D C Gajdusek; L G Goldfarb
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

7.  Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII--and their population frequency.

Authors:  J B Sherman; N Raben; C Nicastri; Z Argov; H Nakajima; E M Adams; C M Eng; T M Cowan; P H Plotz
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

8.  Rapid prenatal diagnosis of trisomy 21 by real-time quantitative polymerase chain reaction with amplification of small tandem repeats and S100B in chromosome 21.

Authors:  Young Ho Yang; Mi Suk Nam; Eun Suk Yang
Journal:  Yonsei Med J       Date:  2005-04-30       Impact factor: 2.759

9.  Overexpression of liver-type phosphofructokinase (PFKL) in transgenic-PFKL mice: implication for gene dosage in trisomy 21.

Authors:  A Elson; D Levanon; Y Weiss; Y Groner
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

Review 10.  Molecular genetics of human chromosome 21.

Authors:  P C Watkins; R E Tanzi; S V Cheng; J F Gusella
Journal:  J Med Genet       Date:  1987-05       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.